Higher CSF tau is correlated with impaired performance on cognitive tests of naming and memory when tested in mixed groups of patients with PD and PDD [50, 53], and CSF tau is slightly higher in patients with PD and cognitive involvement (33/36 of whom had PD-MCI) [56]. This evidence concerns the gene MAPT and Parkinson disease.